Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

5.72USD
7 Dec 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$5.72
Open
$5.74
Day's High
$5.89
Day's Low
$5.51
Volume
97,283
Avg. Vol
140,354
52-wk High
$14.62
52-wk Low
$4.92

Chart for

About

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. The Company has developed a platform that enables it to identify cancer targets, find and genetically engineer TCR,... (more)

Overall

Beta: --
Market Cap(Mil.): $763.12
Shares Outstanding(Mil.): 93.52
Dividend: --
Yield (%): --

Financials

  ADAP.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -1.00 -- --
ROI: -32.06 0.28 15.02
ROE: -35.60 0.94 16.60

Earnings vs. Estimates